Quantitative analysis of glycosylated hemoglobin by immunocappillary electrophoresis

• US 5,431,793 A
• Filed: 07/29/1994
• Issued: 07/11/1995
• Est. Priority Date: 07/29/1994
• Status: Expired due to Term

• Current Assignee: Beckman Instruments, Inc. (Danaher Corporation)
• Original Assignee: Beckman Instruments, Inc. (Danaher Corporation)
• Inventors: Safarian, Zara, Wang, Hann-Ping
• Primary Examiner(s): Niebling, John
• Assistant Examiner(s): DELACROIX MUIRHEI, CYBILLE
• Application Number:
  US08/283,137
• Time in Patent Office: 347 Days
• Field of Search: 204/299 R, 204/182.8, 204/180.1, 436/538, 436/517
• US Class Current: 204/452
• CPC Class Codes: G01N 27/44726 using specific dyes, markers or binding molecules

Abstract

A method useful for determining the content of a first hemoglobin in a blood sample which also contains other forms of hemoglobin is based on capillary electrophoresis. In the method, a specific binding partner to the first form of hemoglobin is added to the sample, and the sample is then subjected to capillary electrophoresis. The method is particularly suited for the determination of the percentage of Hb A_1c in a blood sample using anti-Hb A_1c antibody.

Claims

1. A method for determining the content of a first form of hemoglobin in a sample that also contains at least one other form of hemoglobin, the method comprising the steps of:

(a) adding to a sample containing a first form of hemoglobin and at least one other form of hemoglobin, a macromolecular specific binding partner for the first form of hemoglobin, the specific binding partner specifically binding the first form to yield a complex and not binding to the other forms of hemoglobin in the sample;

(b) subjecting the sample, after step (a), to capillary electrophoresis to generate an electropherogram that separates the complex from the other forms of hemoglobin in the sample; and

(c) determining the content of the first form of hemoglobin in the sample from the electropherogram.

2. The method of claim 1 wherein the first form of hemoglobin is a glycosylated hemoglobin.

3. The method of claim 2 wherein the glycosylated hemoglobin is hemoglobin A_1c.

4. The method of claim 3 wherein the macromolecular specific binding partner is an antibody that specifically binds Hb A_1c and lacks significant binding affinity for Hb A and other hemoglobin variants.

5. The method of claim 4 wherein step (c) comprises determining the ratio of Hb A_1c to Hb in the sample.

6. The method of claim 4 wherein the step of determining quantity comprises measuring light absorption at 214 nm in the electropherogram.

7. The method of claim 1 further comprising the steps of:

(d) adding a known quantity of an internal standard compound to the sample prior to capillary electrophoresis, the internal standard compound being separable from the hemoglobin and being detectable in the electropherogram by a signal proportional to the quantity of internal standard compound;

(e) measuring the signal produced by the internal standard compound in the electropherogram; and

(f) determining the absolute concentration of the first form of hemoglobin in the sample from a standard curve of protein concentration versus the ratio of protein signal to internal standard signal.

8. The method of claim 7 wherein the first form of hemoglobin is Hb A_1c.

9. The method of claim 7 wherein the internal standard compound is 2,4-dichlorobenzoic acid.

10. A method for determining the Hb A_1c content of a sample that also contains at least one other form of hemoglobin, the method comprising the steps of:

(a) adding to a sample containing Hb A_1c and at least one other form of hemoglobin, an antibody specific binding partner for the Hb A_1c, the antibody specifically binding Hb A_1c to yield a complex, the antibody not binding to the other forms of hemoglobin in the sample;

(b) subjecting the sample, after step (a), to capillary electrophoresis utilizing a buffer to generate an electropherogram that separates the complex from the other forms of hemoglobin in the sample, the buffer comprising;

(i) water;

(ii) boric acid in an amount of from 50 to 150 mM;

(iii) a borate salt in an amount of from 15 to 35 mM;

(iv) a sodium or potassium salt where the anion is selected from the group consisting of sulfate, chloride, fluoride, iodide, and bromide ions, the amount of sodium or potassium salt being from 50 to 100 mM; and

(v) sufficient base compound that the buffer has a pH of from 8 to 10; and

(c) determining the quantity of Hb A_1c from the electropherogram.

11. The method of claim 10 wherein the buffer comprises boric acid in an amount of from 75 to 125 mM.

12. The method of claim 10 wherein the borate salt is borax, and the borax is present in an amount of from 20 to 30 mM.

13. The method of claim 10 wherein the amount of sodium or potassium salt in the buffer is from 70 to 80 mM.

14. The method of claim 10 wherein the sodium or potassium salt is sodium chloride.

15. The method of claim 10 wherein the buffer comprises a sufficient base compound that the buffer has a pH of about 8.8.

16. A method for determining the Hb A_1c content of a sample that also contains at least one other form of hemoglobin, the method comprising the steps of:

(a) adding to a sample containing Hb A_1c and at least one other form of hemoglobin, an antibody specific binding partner for the Hb A_1c, the antibody specifically binding Hb A_1c to yield a complex, the antibody not binding to the other forms of hemoglobin in the sample;

(b) subjecting the sample, after step (a), to capillary electrophoresis utilizing a buffer, to generate an electropherogram that separates the complex from the other forms of hemoglobin in the sample, the buffer comprising;

(i) water;

(ii) boric acid in an amount of about 75 mM;

(iii) borax in an amount of about 25 mM;

(iv) sodium chloride in an amount of about 75 mM; and

(v) sufficient sodium hydroxide that the buffer has a pH of about 8.8; and

(c) determining the quantity of Hb A_1c from the electropherogram.

17. A method for determining the content of a first form of hemoglobin in a sample that also contains at least one other form of hemoglobin, the method comprising the steps of:

(a) adding to a sample containing a first form of hemoglobin and at least one other form of hemoglobin, a macromolecular specific binding partner for the first form of hemoglobin, the specific binding partner specifically binding the first form to yield a complex, the antibody not binding to the other forms of hemoglobin in the sample;

(b) subjecting the sample, after step (a), to capillary electrophoresis to generate an electropherogram that separates the complex from the other forms of hemoglobin in the sample; and

(c) determining the content of the first form of hemoglobin in the sample by measuring light absorbance at a wavelength at which hemoglobin significantly absorbs light and at which the macromolecular specific binding partner does not substantially absorb light.

18. The method of claim 17 wherein the first form of hemoglobin is a glycosylated hemoglobin.

19. The method of claim 17 wherein the glycosylated hemoglobin is Hb A_1c.

20. The method of claim 19 wherein the macromolecular specific binding partner is an antibody specific for Hb A_1c.

21. The method of claim 17 wherein the step of capillary electrophoresis comprises utilizing a buffer, the buffer comprising:

(i) water;

(ii) boric acid in an amount of from 50 to 150 mM;

(iii) a borate salt in an amount of from 15 to 35 mM;

(iv) a sodium or potassium salt where the anion is selected from the group consisting of sulfate, chloride, fluoride, iodide, and bromide ions, the amount of sodium or potassium salt being from 50 to 100 mM; and

(v) sufficient base compound that the buffer has a pH of from 8 to 10.

22. The method of claim 21 wherein the buffer comprises (i) water;

(ii) boric acid in an amount of about 75 mM;

(iii) borax in an amount of about 25 mM;

(iv) sodium chloride in an amount of about 75 mM; and

(v) sufficient sodium hydroxide that the buffer has a pH of about 8.8.

23. The method of claim 21 wherein the wavelength at which light absorbance is measured is 415 nm.

24. The method of claim 17 further comprising the steps of:

(d) adding a known quantity of an internal standard compound to the sample prior to capillary electrophoresis, the internal standard compound being separable from the hemoglobin and being detectable in the electropherogram by a signal proportional to the quantity of internal standard compound;

(e) measuring the signal produced by the internal standard compound in the electropherogram; and

(f) determining the absolute concentration of the first form of hemoglobin in the sample from a standard curve of protein concentration versus the ratio of protein signal to internal standard signal.

25. The method of claim 24 wherein the internal standard compound is 2,4-dichlorobenzoic acid and wherein the measurement of the signal produced by the internal standard compound comprises determining the absorbance of the 2,4-dichlorobenzoic acid at 214 nm.